Ofatumumab (Anti-CD20)

Ofatumumab (Anti-CD20) is a fully human, high-affinity IgG1 monoclonal antibody directed against the B cell CD20 cell surface antigen with potential antineoplastic activity. MW: 145.94 kD.

• Supplier: Selleck Chemicals
• Product #: A2971
• Sku #: A2971-1mg